Company: Daewon Pharmaceutical Company Limited
Bloomberg ticker: 003220 KS
Market cap: US$364m
Background: Daewon Pharmaceutical Company Limited produces and sells pharmaceutical products. The company offers multivitamins, antipyretics, analgesics and anti-inflammatory, gastrointestinal, endocrine, antimicrobial, psychoneurotic, respiratory, cardiovascular, and neuromuscular drugs. Daewon Pharmaceutical is headquartered in Seoul, Korea.
World Class Benchmarking of Daewon Pharmaceutical
(Click on image to enlarge)
- Profitable Growth rank of 3 was same compared to the prior period’s 3rd rank
- This is above average performance compared to 410 medium Health Care companies worldwide
- Profitability rank of 3 was worse than its Growth rank of 2
- Profitability rank of 3 was the same compared to the prior period’s 3rd rank
- This is above average performance compared to peers
- Growth rank of 2 was up compared to the prior period’s 4th rank
- This is World Class performance compared to peers
Comments
Log in or sign up to join the conversation.